An AI framework has been developed that analyzes multiple signals in cell-free DNA to detect cancer from blood samples. Using ...

YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation–based cancer detection technology and ophthalmologic innovations, today announced that its ...

The concept of biological age, distinct from chronological age, is gaining public traction, though often misinterpreted. "Aging clocks" are real, but beware of hype.

The prostate is the single organ most frequently afflicted by cancer in men. Prostate cancer affects approximately 4 million American men, with another 330,000 men expected to be diagnosed with the ...

For more than a century, tissue biopsies have stood as the gold standard for diagnosing cancer. And for good reason. These ...

Geviti introduces clinical-grade genetics and Makor AI, combining DNA, biomarkers, and AI into personalized preventative care ...

With liquid biopsies, detecting cancer and tracking treatment progress can be as easy as taking a blood test. This is an increasingly popular way of monitoring cancer, because it's much less invasive ...

A novel epigenetic therapy has demonstrated activity against treatment-resistant acute myeloid leukaemia in preclinical ...

Parkinson’s disease affects more males than females and they tend to have a higher risk. A new study in brain cells sheds ...

Americans spend nearly $5T a year on healthcare and still trail almost every peer country on outcomes - and a NYC startup ...

The patented platform combines genome sequencing, methylation analysis and machine learning to detect cancer and identify its ...